Soo YeonKangMD

PubMed

• Ampullary and periampullary tumors: translational efforts to meet a challenge in diagnosis and treatment. Highlights from the "2011 ASCO Gastrointestinal Cancers Sympo...
  Kang, S. P., Saif, M. W.> ;JOP. 2011 Mar
• Three-drug combination regimen in pancreatic cancer treatment: are we there yet?
  Kang, S. P., Saif, M. W.> ;JOP. 2011 Mar
• Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products.
  Kang, S. P., Ratain, M. J.> ;Clin Cancer Res. 2010 Sep 1
• A pharmacogenetic study of vorinostat glucuronidation.
  Kang, S. P., Ramirez, J., House, L., Zhang, W., Mirkov, S., Liu, W., Haverfield, E., Ratain, M. J.> ;Pharmacogenet Genomics. 2010 Oct
• Clinical outcome of pancreatic cancer patients with diabetes mellitus: is diabetes a poor prognostic factor? Highlights from the "2010 ASCO Annual Meeting". Chicago, I...
  Kang, S. P., Saif, M. W.> ;JOP. 2010
• Circulating tumor cells in HER-2 positive metastatic breast cancer patients treated with trastuzumab and chemotherapy.
  Nunes, R. A., Li, X., Kang, S. P., Burstein, H., Roberts, L., Carney, W., Blackwell, K., Ryan, P., Borges, V., Iglehart, J. D., Friedman, P., Harris, L. N.> ;Int J Biol Markers. 2009 May 01
• Global variation in CYP2C8-CYP2C9 functional haplotypes.
  Speed, W. C., Kang, S. P., Tuck, D. P., Harris, L. N., Kidd, K. K.> ;Pharmacogenomics J. 2009 Aug 01
• Pharmacogenomics and pancreatic cancer treatment. Optimizing current therapy and individualizing future therapy.
  Kang, S. P., Saif, M. W.> ;JOP. 2008
• Pseudocirrhosis in a pancreatic cancer patient with liver metastases: a case report of complete resolution of pseudocirrhosis with an early recognition and management.
  Kang, S. P., Taddei, T., McLennan, B., Lacy, J.> ;World J Gastroenterol. 2008 Mar 14
• Optimal second line treatment options for gemcitabine refractory advanced pancreatic cancer patients. Can we establish standard of care with available data?
  Kang, S. P., Saif, M. W.> ;JOP. 2008
• Triple negative breast cancer: current understanding of biology and treatment options.
  Kang, S. P., Martel, M., Harris, L. N.> ;Curr Opin Obstet Gynecol. 2008 Feb
• Infusion-related and hypersensitivity reactions of monoclonal antibodies used to treat colorectal cancer--identification, prevention, and management.
  Kang, S. P., Saif, M. W.> ;J Support Oncol. 2007 Oct
• Long-term survival on capecitabine in two gemcitabine refractory pancreatic cancer patients. Is there a pharmacogenetic explanation?
  Saif, M. W., Kang, S. P., Ledbetter, L., Steg, A., Diasio, R., Johnson, M.> ;JOP. 2007
• Join now to see all